Source: Pharmabiz

Axcension: iMedX completes acquisition of Prevalent and Axcension

iMedX, Inc, an international leader in revenue cycle management, medical documentation, and health information solutions, has successfully completed the acquisition of Prevalent, Inc and Axcension,

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more